Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
DarioHealth
DRIO
DarioHealth
Digital Health Onboarding Delays And Rising Costs Will Ease Eventually
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
18 Aug 25
Updated
18 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$0.60
26.7% undervalued
intrinsic discount
18 Aug
US$0.44
Loading
1Y
-52.2%
7D
2.7%
Author's Valuation
US$0.6
26.7% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$0.6
26.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-65m
64m
2014
2017
2020
2023
2025
2026
2028
Revenue US$64.4m
Earnings US$5.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
18.46%
Healthtech revenue growth rate
4.71%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
11.71%
Calculation
US$5.64m
Earnings '28
x
14.82x
PE Ratio '28
=
US$83.62m
Market Cap '28
US$83.62m
Market Cap '28
/
99.96m
No. shares '28
=
US$0.84
Share Price '28
US$0.84
Share Price '28
Discounted to 2025 @ 11.71% p.a.
=
US$0.60
Fair Value '25
